Ch: Siegfried affected by attack on its IT systems


Siegfried pharmaceutical published a statement on its web site on May 23:

The Siegfried Group’s IT network has become the target of a malware attack. The company immediately initiated extensive measures to ensure the safety of its employees and facilities at all times and to avert further damage. The root cause has been identified and the recovery of the systems has started.

In the night to Friday, May 21, 2021, an attack with malware on Siegfried’s IT network was discovered by internal monitoring systems. As an immediate measure, production was shut down at various sites, network connections were interrupted and all IT systems were subjected to an in-depth investigation, which is currently still ongoing. The safety of all employees and production facilities was guaranteed at all times. With the exception of the two sites in Spain, which operate on an isolated network, there will be varying degrees of production interruption at the other sites.

Cooperation of internal and external specialists for IT infrastructure and security is running smoothly and efficiently. In the meantime, the root cause has been identified and the recovery of the systems has started. This also includes the assessment by when the IT systems will be fully operational again.

Although the firm says “malware” and doesn’t specifically mention “ransomware,”  we may learn more in time and will update this post. But added one detail of note in their coverage:

The Siegfried production facility in Hameln, Germany was also affected by the attack. The Covid BioNTech vaccine, developed by the American pharmaceutical company Pfizer, was recently packaged there. Media spokesperson Peter Geller confirmed upon request: “Production in Hamelin is also discontinued. But this morning we’ve put everything on the right track so we can start the systems up slowly again. ”However, since these programs contain very complex control programs, it may take some time before production is fully ramped up.

Additional material by Dissent

About the author: chum1ng0

Comments are closed.